Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus

por Zhu, Lisa, Singh, Manpreet, Lele, Sonia, Sahakian, Lori, Grossman, Jennifer, Hahn, Bevra, McMahon, Maureen
Publicado 2022

Comparison of PREDICTS atherosclerosis biomarker changes after initiation of new treatments in patients with SLE

por McMahon, Maureen, Skaggs, Brian, Grossman, Jennifer, Wong, Weng Kee, Sahakian, Lori, Chen, Weiling, Hahn, Bevra
Publicado 2019

High score on PREDICTS is associated with 10-fold increased odds for the progression of subclinical atherosclerosis in SLE

por McMahon, M, Sahakian, Lori, Grossman, J, Skaggs, B, Fitzgerald, J, Charles-Schoeman, C, Ragavendra, N, Gorn, A, Karpouzas, G, Weisman, M, Wallace, D, Hahn, B
Publicado 2012

A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus

por Skaggs, Brian J., Grossman, Jennifer, Sahakian, Lori, Perry, Lucas, FitzGerald, John, Charles‐Schoeman, Christina, Gorn, Alan, Taylor, Mihaela, Moriarty, John, Ragavendra, Nagesh, Weisman, Michael, Wallace, Daniel J., Hahn, Bevra H., McMahon, Maureen
Publicado 2021

High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids

por McMahon, Maureen, Skaggs, Brian J, Sahakian, Lori, Grossman, Jennifer, FitzGerald, John, Ragavendra, Nagesh, Charles-Schoeman, Christina, Chernishof, Marissa, Gorn, Alan, Witztum, Joseph L, Wong, Weng Kee, Weisman, Michael, Wallace, Daniel J, La Cava, Antonio, Hahn, Bevra H
Publicado 2011